Cardiff Oncology Inc. buy secretariat
Start price
19.09.20
/
50%
€7.40
Target price
23.09.20
-
Performance (%)
34.46%
End price
23.09.20
€9.95
Summary
This prediction ended on 23.09.20 with a price of €9.95. With a performance of 34.46% the BUY prediction by secretariat was a big success. secretariat has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cardiff Oncology Inc. | -0.855% | -0.855% | -54.826% | -16.051% |
| iShares Core DAX® | -6.016% | -4.595% | 1.284% | 48.459% |
| iShares Nasdaq 100 | 0.511% | 0.164% | 14.401% | 85.254% |
| iShares Nikkei 225® | -7.156% | -2.215% | 27.886% | 50.351% |
| iShares S&P 500 | -0.257% | -0.841% | 10.254% | 58.647% |
According to secretariat what are the pros and cons of Cardiff Oncology Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by secretariat for this prediction
In the thread Trovagene diskutieren
Buy Cardiff Oncology Inc.